Renal Denervation: Are We There Yet?
Edgar Lerma @edgarvlermamd Dr. Edgar Lerma is a clinical nephrologist practicing in the south suburbs of Chicago. He holds the rank of Clinical
Edgar Lerma @edgarvlermamd Dr. Edgar Lerma is a clinical nephrologist practicing in the south suburbs of Chicago. He holds the rank of Clinical
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are an emerging class of medications that have become increasingly popular in medication regimens
It is widely accepted that estimated glomerular filtration rate (eGFR) and urine albumin creatinine ratio have been used as measures in chronic
A recent AJKD Core Curriculum from Vondracek et al tackles the broad topic of pharmacotherapy. In this piece, the authors discuss basic principles
With the prevalence of urinary stone disease (USD) nearly doubling over the last 15 years, there has been a concomitant rise in the impact it has on
A recent Core Curriculum in AJKD from Theresa K. Chen and colleagues focuses on one of the most bread-and-butter topics for nephrology—reducing
Image from Pixabay / Gerald SARS-CoV2 is a virus that has shaken the scientific community to its core. As we struggle to catch up to a rapidly
The coronavirus (SARS-CoV-2) pandemic of 2019 is an unparalleled time in our history with an unprecedented strain on the US healthcare system,
With the Advancing American Kidney Health Initiative (AAKHI), there has been renewed interest in home dialysis, particularly peritoneal dialysis (PD)
Many different definitions of contrast-induced nephropathy (CIN) have appeared in the literature since it was first reported in 1954. It is commonly
The “Nephrology Quiz and Questionnaire 2019” session was held on Nov 7, 2019, at the ASN #KidneyWk in Washington, DC. Click here for more
The “Linking Lifestyle, BP, and Kidney Diseases: What Is the Evidence?” session was held on Nov 7, 2019, at the ASN #KidneyWk in Washington,
The “Drilling Down on Acute Interstitial Nephritis” session was held on Nov 8, 2019, at the ASN #KidneyWk in Washington, DC. I had the distinct
Intradialytic hypotension (IDH) is sometimes defined as a decrease in systolic BP by ≥20 mm Hg or a decrease in mean arterial pressure of 10 mm Hg
There has been significant interest in SGLT2 inhibitors (SGLT2i) as novel oral anti-hyperglycemic agents that have been recently approved for the